Summary
Full Transcript
Are you ready to navigate the intricate landscape of medical software approval? This lesson delves into the regulatory processes governing medical software, highlighting key considerations from initial agency review to market release. We'll cover how risk classification impacts approval pathways and explore distinct regulatory frameworks in the United States, European Union, and China. 🎯 Learning Objectives • Understand the core principles regulatory agencies apply when reviewing medical software, focusing on efficacy, safety, and security. • Differentiate between device classifications (Class I, II, III) and their corresponding review processes, including 510k, De Novo, and Pre-Market Approval (PMA) in the US. • Explain the distinctions and applications of general controls and special controls in medical device regulation. • Compare and contrast the regulatory frameworks and approval processes for medical software in the United States (FDA), European Union (MDR), and China (NMPA).
